home / stock / oacb / oacb news


OACB News and Press, Oaktree Acquisition Corp. II Class A From 03/21/22

Stock Information

Company Name: Oaktree Acquisition Corp. II Class A
Stock Symbol: OACB
Market: NYSE

Menu

OACB OACB Quote OACB Short OACB News OACB Articles OACB Message Board
Get OACB Alerts

News, Short Squeeze, Breakout and More Instantly...

OACB - Oaktree Acquisition Corp. II started at outperform at Northland ahead of Alvotech merger

Northland has initiated SPAC Oaktree Acquisition Corp. II (NYSE:OACB -0.3%) with an outperform rating ahead of its planned merger with Icelandic biotech Alvotech. The acquisition, announced in December, values Alvotech at $2.25B. Northland has a $15 price target (~51% upside based on Fri...

OACB - Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech's Proposed High-Concentration Biosimilar (AVT02) for Humira®

Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023 All ongoing U.S. disputes between AbbVie and Alvotech have been resolved, including the ITC action brought forth in December 2021 Alvotech Holdings S.A. ...

OACB - Alvotech Upsizes Oversubscribed PIPE Transaction to Approximately $175 Million

Alvotech Holdings S.A. (“Alvotech”), a leading global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition Corp. II (“Oaktree II”) (NYSE: OACB), a publicly traded s...

OACB - Merger Arbitrage Mondays: Saint-Gobain Acquires GCP Applied Technologies

Saint-Gobain acquires GCP for $32 per share, representing a premium of 21.12%. The tiny 0.72% spread on the GCP deal despite this being a cross-border deal, implies the market might be expecting a competing offer for. JACK wants to eat its TACO, paying a grande premium of over 66%...

OACB - SPAC Oaktree Acquisition to take Alvotech public at $2.25B valuation

Alvotech Holdings S.A., a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide to list on Nasdaq under the symbol “ALVO" through business combination with SPAC Oaktree Acquisition Corp. II (NYSE:OACB). The deal is ex...

OACB - Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company

Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets. Biosimilars are therapeutic equivalents to biologics, a rapidly growing category of highly efficacious medicines Transa...

OACB - Alphyn Capital Management Q3 2021 Investor Letter

Alphyn Capital Management, LLC is a registered investment advisor focussed on a) great public companies that have the power to endure, with long runways to grow through reinvesting cash flows at high rates of return, run by talented and aligned operators and b) the occasional special situ...

OACB - Alphyn Capital Management Q2 2021 Investor Letter

Alphyn Capital Management, LLC is a registered investment advisor focussed on a) great public companies that have the power to endure, with long runways to grow through reinvesting cash flows at high rates of return, run by talented and aligned operators and b) the occasional special situ...

OACB - Alphyn Capital Management Q1 2021 Investor Letter

Alphyn Capital Management, LLC is a registered investment advisor focussed on a) great public companies that have the power to endure, with long runways to grow through reinvesting cash flows at high rates of return, run by talented and aligned operators and b) the occasional special situ...

Previous 10 Next 10